Detalhe da pesquisa
1.
Propargylamine-derived multi-target directed ligands for Alzheimer's disease therapy.
Bioorg Med Chem Lett
; 30(3): 126880, 2020 02 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31864798
2.
Exploring the structural basis of the selective inhibition of monoamine oxidase A by dicarbonitrile aminoheterocycles: role of Asn181 and Ile335 validated by spectroscopic and computational studies.
Biochim Biophys Acta
; 1844(2): 389-97, 2014 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-24247011
3.
Predicting targets of compounds against neurological diseases using cheminformatic methodology.
J Comput Aided Mol Des
; 29(2): 183-98, 2015 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-25425329
4.
Multicomponent Reactions for Multitargeted Compounds for Alzheimer`s Disease.
Curr Top Med Chem
; 17(31): 3319-3327, 2017.
Artigo
Inglês
| MEDLINE | ID: mdl-29332584
5.
Galanthamine, a natural product for the treatment of Alzheimer's disease.
Recent Pat CNS Drug Discov
; 1(1): 105-11, 2006 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-18221196
6.
The multifactorial nature of Alzheimer's disease and related therapeutic strategies.
Curr Pharm Des
; 16(25): 2765, 2010.
Artigo
Inglês
| MEDLINE | ID: mdl-20698817
7.
Synthesis and pharmacology of galantamine.
Chem Rev
; 106(1): 116-33, 2006 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-16402773